Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.87)
# 3,104
Out of 4,931 analysts
173
Total ratings
45.21%
Success rate
-1.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $3 → $4 | $3.50 | +14.29% | 16 | Jul 15, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $107 | $91.39 | +17.08% | 10 | Jul 15, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $160 → $147 | $157.39 | -6.60% | 17 | Jul 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $97.70 | -2.76% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $465.09 | +39.76% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $10.21 | +17.53% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $117.65 | -19.25% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $85.21 | -0.24% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $32.74 | -54.18% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $286.81 | +19.59% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.65 | +751.06% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $23.22 | +106.72% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $77.53 | +31.56% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $102.48 | -43.40% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $14.03 | +42.55% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $75.95 | +72.48% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $131.99 | +0.77% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $376.41 | -41.55% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $116.29 | +225.05% | 2 | Feb 25, 2022 |
Sight Sciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $3 → $4
Current: $3.50
Upside: +14.29%
Medtronic
Jul 15, 2025
Maintains: Overweight
Price Target: $98 → $107
Current: $91.39
Upside: +17.08%
iRhythm Technologies
Jul 15, 2025
Maintains: Overweight
Price Target: $160 → $147
Current: $157.39
Upside: -6.60%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $97.70
Upside: -2.76%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $465.09
Upside: +39.76%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $10.21
Upside: +17.53%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $117.65
Upside: -19.25%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $85.21
Upside: -0.24%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $32.74
Upside: -54.18%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $286.81
Upside: +19.59%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.65
Upside: +751.06%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $23.22
Upside: +106.72%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $77.53
Upside: +31.56%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $102.48
Upside: -43.40%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $14.03
Upside: +42.55%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $75.95
Upside: +72.48%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $131.99
Upside: +0.77%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $376.41
Upside: -41.55%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $116.29
Upside: +225.05%